Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Gnatocerus cornutus genome sequencing adult male

PROVIDER: PRJNA944226 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR16119349_subreads.fastq.gz	Fastqsanger.gz
	SRR18334047_1.fastq.gz	Fastqsanger.gz
	SRR18334047_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Project description:Gnatocerus cornutus genome sequencing adult male principal pseudohaplotype

| PRJNA767424 | ENA

Gnatocerus cornutus

Project description:Genome sequencing of Gnatocerus cornutus adult male alternate pseudohaplotype

| PRJNA816610 | ENA

Gnatocerus cornutus strain:Japan

Project description:Gnatocerus cornutus genome sequencing

| PRJDB16211 | ENA

Gnatocerus cornutus

Project description:Gnatocerus cornutus overview

| PRJNA991695 | ENA

Gnatocerus cornutus strain:Miyazaki, Japan

Project description:Genome and transcriptomic analysis of Gnatocerus cornutus

| PRJDB16215 | ENA

E-GEOD-72095

Project description:Transcription profiling by high throughput sequencing of dissected tissue of the suprachiasmatic nucleus from five adult male mice

2016-12-16 | E-GEOD-72095 | ExpressionAtlas

E-GEOD-34305

Project description:Gene expression profile of adult male offspring from ethanol-consuming mice

2015-09-22 | E-GEOD-34305 | ExpressionAtlas

E-MTAB-698

Project description:RNA-seq of vomeronasal tissue from adult male and female mice

2019-05-14 | E-MTAB-698 | ExpressionAtlas

E-GEOD-74747

Project description:RNA-seq of 9 tissues from an adult male C57BL/6 mouse

2016-05-13 | E-GEOD-74747 | ExpressionAtlas

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data